SYMBIOTIC.BLUE

Symbiotic.blue is a pre-seed biotech company developing an AI-driven drug discovery platform that combines generative AI with neuroscience-inspired computational methods.

The platform aims to design molecules capable of acting on multiple biological targets simultaneously, with an initial focus on obesity.

The company was founded by academics from the Universities of Oxford and Cambridge alongside life sciences industry veterans.